TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 93 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $754,766 | -1.9% | 41,769 | -31.7% | 0.00% | – |
| Q1 2023 | $769,008 | -7.5% | 61,178 | +7.8% | 0.00% | – |
| Q4 2022 | $831,721 | +19.5% | 56,734 | +39.5% | 0.00% | – |
| Q3 2022 | $696,000 | +11.9% | 40,663 | -4.6% | 0.00% | – |
| Q2 2022 | $622,000 | +32.1% | 42,617 | +52.3% | 0.00% | – |
| Q1 2022 | $471,000 | -12.5% | 27,982 | +17.1% | 0.00% | – |
| Q4 2021 | $538,000 | -12.7% | 23,904 | -16.5% | 0.00% | – |
| Q3 2021 | $616,000 | -30.2% | 28,614 | -6.0% | 0.00% | – |
| Q2 2021 | $882,000 | -6.5% | 30,428 | +4.0% | 0.00% | – |
| Q1 2021 | $943,000 | +17.7% | 29,259 | +51.1% | 0.00% | – |
| Q4 2020 | $801,000 | – | 19,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,034,158 | $25,569,366 | 3.81% |
| Vivo Capital, LLC | 2,262,200 | $28,435,854 | 1.97% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $22,469,214 | 1.63% |
| Cormorant Asset Management, LP | 1,421,422 | $17,867 | 1.18% |
| Sands Capital Ventures, LLC | 260,000 | $3,268,200 | 0.81% |
| RTW INVESTMENTS, LP | 2,548,125 | $32,029,931 | 0.67% |
| Perceptive Advisors | 1,296,416 | $16,295,949 | 0.48% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,156,032 | $14,531,322 | 0.32% |
| Ghost Tree Capital, LLC | 80,000 | $1,006,000 | 0.30% |
| TimesSquare Capital Management, LLC | 1,192,660 | $14,992 | 0.22% |